Large-scale compounding pharmacies may soon be subject to FDA regulations under a new federal law, according to NBC News.
The drug quality and security act encourages large drug compounding plants, which make custom blends of medicines, to register with the FDA and comply with regular inspections.
The FDA will not be able to track pharmacies that do not choose to register, but it will encourage health care providers to only purchase products from regulated facilities to protect the health and safety of their patients.
The law is in response to tainted steroid injections mixed at a Massachusetts compounding center that killed 64 people and made 750 other sick last year.
Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Sandy Youngblut at 319-291-1259. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at email@example.com.